HCW Biologics Inc.
(HCWB)
undefined
undefined%
At close: undefined
0.37
0.05%
After-hours Dec 13, 2024, 07:26 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -24.99M | -14.90M | -12.86M | -5.80M | -7.29M |
Depreciation & Amortization | 1.14M | 717.85K | 543.60K | 595.91K | 421.82K |
Stock-Based Compensation | 1.00M | 1.12M | 360.98K | 21.88K | 1.76K |
Other Working Capital | -5.14M | 2.35M | -2.80M | -2.12M | -662.22K |
Other Non-Cash Items | 4.98M | 188.46K | 28.26K | 4.32M | 79.00K |
Deferred Income Tax | - | - | -501.48K | -4.32M | -79.00K |
Change in Working Capital | -4.64M | 2.49M | 1.46M | -5.25M | 104.17K |
Operating Cash Flow | -22.51M | -10.39M | -10.98M | -10.43M | -6.77M |
Capital Expenditures | -6.20M | -10.28M | -47.26K | -186.68K | -1.46M |
Acquisitions | - | - | - | - | - |
Purchase of Investments | - | - | -34.97M | - | - |
Sales Maturities Of Investments | 10.00M | 24.98M | - | - | - |
Other Investing Acitivies | - | 24.98M | -34.97M | - | 164.00 |
Investing Cash Flow | 3.80M | 14.71M | -35.02M | -186.68K | -1.46M |
Debt Repayment | -38.27K | 6.45M | - | 563.59K | - |
Common Stock Repurchased | - | - | - | - | - |
Dividend Paid | - | - | -2.82M | - | - |
Other Financial Acitivies | - | -190.55K | -6.76M | 22.30M | 26.83M |
Financial Cash Flow | -14.53K | 6.27M | 49.27M | 11.72M | 13.45M |
Net Cash Flow | -18.73M | 10.60M | 3.27M | 1.10M | 5.22M |
Free Cash Flow | -28.72M | -20.66M | -11.02M | -10.62M | -8.23M |